FRM
Fox Run Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,734
| Closed | -$1.1M | – | 1164 |
|
|
2025
Q1 | $1.1M | Buy |
+1,734
| New | +$1.1M | 0.17% | 172 |
|
|
2024
Q4 | – | Sell |
-452
| Closed | -$475K | – | 1129 |
|
|
2024
Q3 | $475K | Buy |
+452
| New | +$475K | 0.11% | 373 |
|
|
2024
Q2 | – | Sell |
-721
| Closed | -$694K | – | 1020 |
|
|
2024
Q1 | $694K | Buy |
721
+45
| +7% | +$43.3K | 0.15% | 259 |
|
|
2023
Q4 | $594K | Buy |
676
+363
| +116% | +$319K | 0.15% | 236 |
|
|
2023
Q3 | $258K | Buy |
+313
| New | +$258K | 0.08% | 494 |
|
|
2021
Q4 | – | Sell |
-417
| Closed | -$252K | – | 669 |
|
|
2021
Q3 | $252K | Buy |
+417
| New | +$252K | 0.16% | 292 |
|
|
2020
Q4 | – | Sell |
-376
| Closed | -$210K | – | 268 |
|
|
2020
Q3 | $210K | Buy |
+376
| New | +$210K | 0.53% | 111 |
|
|
2018
Q1 | – | Sell |
-2,953
| Closed | -$1.11M | – | 886 |
|
|
2017
Q4 | $1.11M | Buy |
+2,953
| New | +$1.11M | 0.33% | 52 |
|
|
2017
Q1 | – | Sell |
-1,200
| Closed | -$441K | – | 718 |
|
|
2016
Q4 | $441K | Buy |
+1,200
| New | +$441K | 0.23% | 166 |
|
|
2016
Q3 | – | Sell |
-1,400
| Closed | -$489K | – | 650 |
|
|
2016
Q2 | $489K | Sell |
1,400
-1,300
| -48% | -$454K | 0.24% | 136 |
|
|
2016
Q1 | $973K | Buy |
+2,700
| New | +$973K | 0.65% | 8 |
|